Comparing the efficacy of regen-cov, remdesivir, and favipiravir in reducing invasive mechanical ventilation need in hospitalized COVID-19 patients

BACKGROUND: Coronavirus disease 2019 (COVID-19) pandemic stimulates research works to find a solution to this crisis from starting 2020 year up to now. With ending of the 2021-year, various advances in pharmacotherapy against COVID-19 have emerged. Regarding antiviral therapy, casirivimab and imdevi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegazy, Sahar Kmal, Tharwat, Samar, Hassan, Ahmed Hosny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507553/
https://www.ncbi.nlm.nih.gov/pubmed/37731581
http://dx.doi.org/10.12998/wjcc.v11.i26.6105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507553/
https://www.ncbi.nlm.nih.gov/pubmed/37731581
http://dx.doi.org/10.12998/wjcc.v11.i26.6105

Ejemplares similares